Target intelligence / Profile preview

Host cell proteins and membranes

Molecular classification
Other
01

Overview

"Host cell proteins and membranes" are not single, discrete molecular targets but rather broad categories referring to (1) the proteins produced by the host organism—often considered as impurities to be removed during biopharmaceutical manufacturing, due to potential immunogenicity, instability, or reduced efficacy of therapeutic products; and (2) the physical lipid bilayer structure (cell membrane or plasma membrane) encapsulating a cell, involved in compartmentalization, signal transduction, and as the interface for host-pathogen interactions. These terms collectively do not denote a unique biological target such as a receptor, enzyme, or transporter and cannot be specifically targeted by drugs, though individual proteins or components within these broader categories (e.g., a specific membrane protein, such as a receptor, or a defined contaminant protein) may serve as bona fide therapeutic targets or biomarkers in specific contexts.

Other names
Host cell proteinsHost cell membraneHost cell membranes
02

Mechanism of action

Not applicable (no defined, targetable, actionable mechanism as a "target"; individual membrane proteins or host factors may be targeted, but not the broad classes)

03

Biological functions

Cellular compartmentalizationSelective permeabilitySignal transductionCell adhesionImmune recognitionProtein synthesis (for host cell proteins only, via ribosomes and associated factors)
04

Disease associations

Immunogenicity in biopharmaceuticals (host cell proteins as process-related impurities)Entry point for infection (cell membranes as viral entry barrier and route)Other (broad context-dependent effects)
05

Safety considerations

Immunogenicity (host cell protein contamination in biologics causing adverse immune responses)Product purity in biopharmaceuticalsOff-target effects and cytotoxicity if unintentionally targeting host cell functions
06

Interacting drugs

None specifically (as a target class; some drugs and biologics interact with membrane proteins or use host cell machinery during infection or therapy)
07

Biomarkers

Residual host cell proteins (measured for drug purity and safety in biomanufacturing)General cell surface markers (for cell membranes, but not as a broad class; individual membrane proteins or antigens are used as biomarkers)

Beyond the preview

Go deeper on Host cell proteins and membranes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Host cell proteins and membranes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call